baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

UBS Knock-Out JNJ/ DE000UM4GQM9 /

7/15/2024 9:56:40 PM	Chg.-0.070	Bid-	Ask-	Underlying	Strike price	Expiration date	Option type
7.590EUR	-0.91%	- Bid Size: -	- Ask Size: -	Johnson and Johnson	67.0668 USD	12/31/2078	Call

GlobeNewswire 5/28 Numab Therapeutics Announces Johnson & Johnson to Acquire its Wholly-Owned Subsidiary Yellow Jersey ...

TeleTrader 5/1 J&J to pay $6.5 billion to settle US talc-related lawsuits

GlobeNewswire 4/17 TRC Amends Its Tender Offer for Johnson & Johnson

GlobeNewswire 4/10 SWAV Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Sale of Shockwave Medical t...

TeleTrader 4/5 J&J to acquire Shockwave Medical for $13.1B

TeleTrader 3/26 J&J may allegedly acquire Shockwave Medical

GlobeNewswire 3/15 CURE Media Group and Oncology Nursing News Announces the 2024 Extraordinary Healer® Award Finalists

GlobeNewswire 3/6 Ambrx Shareholders Approve Acquisition by Johnson & Johnson

TeleTrader 1/27 J&J, Merck CEOs to testify before Senate on drug prices

TeleTrader 1/24 J&J to pay $149.5M to settle Washington state opioid case

TeleTrader 1/23 J&J to pay $700M in talc powder probe settlement

TeleTrader 1/23 J&J's Q4 sales top estimates, up 7.3% to $21.4B

TeleTrader 1/23 Johnson & Johnson Q4 earnings preview

TeleTrader 1/22 Earnings preview: Tesla takes center stage

TeleTrader 1/8 J&J to buy biotech company Ambrx for $2B

GlobeNewswire 12/4/2023 Nanobiotix Announces Closing of the Remaining $4.8 Million Investment From Johnson & Johnson Innovat...

TeleTrader 11/7/2023 J&J to begin trials with surgical robot

TeleTrader 10/17/2023 J&J's Q3 sales up 6.8% to $21.4 billion

TeleTrader 10/3/2023 J&J's $223.8M talc powder case fine overturned

TeleTrader 8/29/2023 US gov't reveals drugs subject to Medicare price debate

TeleTrader 7/20/2023 J&J highest since January as Q2 results top estimates

TeleTrader 7/20/2023 J&J's Q2 sales rise by 6.3% to $25.5 billion

TeleTrader 7/18/2023 J&J joins drug price suits against US gov't

TeleTrader 5/4/2023 J&J's Kenvue reportedly valued at $41B for IPO

UBS Knock-Out JNJ/ DE000UM4GQM9 /

If you wish to receive reply to your feedback, please provide your email address.